8.000
+0,00%
2025-12-01
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +57.5% | +6.5% | 2 / 3 | +31.6% | -4.36 pp | +1.13 pp | +7.4% | 0.39 | 9.15 | 124 | +31,6% | 8,5 | +57,5% | 9.15 | 10.14 | −9,8% |
| Pts | 8 | 0 | 8 | 12 | 0 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.000 (close price on 2025-12-01)EPS (TTM): 874,4
Financial charts
1.Revenue & growth
VND bn124Q2/26
1.Revenue & growth
VND bn124Q2/26
2.Profit & growth
VND bn8,69Q2/26
3.Profit mix (Penman)
VND bn35,8Q2/26
4.Margins & cost structure
%27.8%Q2/26
5.Returns & cash cycle
% · days8.5%Q2/26
6.Earnings quality & cash
VND bn56,8Q2/26
7.Asset structure
VND bn715Q2/26
8.Funding & debt health
VND bn · times715Q2/26
9.Revenue backlog
VND bn56,8Q2/26
10.Valuation
times · %9,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %268Q2/26
Adjusted EPS growth, latest quarter
60.3%
Average adjusted EPS growth, 3 quarters
7.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26